David S. Secher

4.0k total citations · 2 hit papers
49 papers, 3.4k citations indexed

About

David S. Secher is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, David S. Secher has authored 49 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Radiology, Nuclear Medicine and Imaging, 26 papers in Immunology and 20 papers in Molecular Biology. Recurrent topics in David S. Secher's work include Monoclonal and Polyclonal Antibodies Research (30 papers), Glycosylation and Glycoproteins Research (16 papers) and T-cell and B-cell Immunology (15 papers). David S. Secher is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (30 papers), Glycosylation and Glycoproteins Research (16 papers) and T-cell and B-cell Immunology (15 papers). David S. Secher collaborates with scholars based in United Kingdom, United States and Slovakia. David S. Secher's co-authors include César Milstein, Timothy A. Springer, G. Galfré, D. C. Burke, Nicholas J. Cowan, Richard G.H. Cotton, K Cantell, Veronica van Heyningen, Julia R. Dorin and Michal Novák and has published in prestigious journals such as Nature, Cell and The Journal of Experimental Medicine.

In The Last Decade

David S. Secher

49 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mac‐1: a macrophage differentiation antigen identified by monoclonal antibody

1979 1.0k citations Timothy A. Springer, David S. Secher et al. European Journal of Immunology profile →
Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens

1978 529 citations Timothy A. Springer, David S. Secher et al. European Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David S. Secher United Kingdom	21	1.7k	1.5k	1.4k	368	353	49	3.4k
Joseph Haimovich Israel	29	1.2k 0.7×	1.5k 1.0×	1.3k 0.9×	188 0.5×	284 0.8×	89	2.8k
Sherman Fong United States	36	1.7k 1.0×	809 0.5×	1.2k 0.8×	506 1.4×	443 1.3×	81	3.4k
Vicki L. Sato United States	18	2.0k 1.2×	1.4k 0.9×	817 0.6×	140 0.4×	200 0.6×	23	3.2k
Luciana Forni France	29	2.1k 1.3×	1.3k 0.8×	1.1k 0.8×	129 0.4×	204 0.6×	58	3.3k
E S Vitetta United States	33	2.4k 1.4×	845 0.5×	1.0k 0.7×	139 0.4×	365 1.0×	68	3.2k
E L Reinherz United States	29	2.6k 1.6×	750 0.5×	1.2k 0.9×	219 0.6×	689 2.0×	38	3.8k
S M Colón United States	29	3.8k 2.3×	1.8k 1.2×	1.8k 1.2×	248 0.7×	362 1.0×	40	5.4k
S Carrel Switzerland	37	2.2k 1.3×	1.6k 1.0×	2.4k 1.7×	435 1.2×	1.2k 3.4×	110	4.9k
Rose G. Mage United States	30	1.2k 0.7×	1.4k 0.9×	929 0.7×	166 0.5×	119 0.3×	145	2.9k
Peter D. Burrows United States	35	2.8k 1.7×	1.1k 0.7×	998 0.7×	219 0.6×	438 1.2×	98	4.1k

Countries citing papers authored by David S. Secher

Since Specialization

Citations

This map shows the geographic impact of David S. Secher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Secher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Secher more than expected).

Fields of papers citing papers by David S. Secher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Secher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Secher. The network helps show where David S. Secher may publish in the future.

Co-authorship network of co-authors of David S. Secher

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Secher. A scholar is included among the top collaborators of David S. Secher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Secher. David S. Secher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Begent, Rhj, Kerry Chester, D. Crowther, et al.. (1993). Cancer research campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials. European Journal of Cancer. 29(13). 1907–1910. 14 indexed citations

Adair, John R., et al.. (1991). From laboratory to clinic: the development of an immunological reagent. Immunology Today. 12(4). 130–134. 3 indexed citations

McManus, Michael T., Jane A. McKeating, David S. Secher, et al.. (1988). Identification of a monoclonal antibody to abscission tissue that recognises xylose/fucose-containing N-linked oligosaccharides from higher plants. Planta. 175(4). 506–512. 58 indexed citations

Díaz‐Espada, Fernando, César Milstein, & David S. Secher. (1987). The regulation of membrane-bound and secreted immunoglobulins in the human lymphoid cell line LICR-LON and human hybridomas. Molecular Immunology. 24(6). 595–603. 4 indexed citations

Scott, G.M., et al.. (1985). Measurement of Interferon from in vitro Stimulated Lymphocytes by Bioassay and Monoclonal Antibody-based Immunoassay. Journal of General Virology. 66(7). 1621–1625. 7 indexed citations

Scott, G.M., James K. Onwubalili, J. A. Robinson, et al.. (1985). Tolerance of one‐month intranasal interferon. Journal of Medical Virology. 17(2). 99–106. 17 indexed citations

Evans, Tom & David S. Secher. (1984). Kinetics of internalisation and degradation of surface-bound interferon in human lymphoblastoid cells.. The EMBO Journal. 3(12). 2975–2978. 13 indexed citations

Coulie, Pierre G., et al.. (1983). Determinants recognized by murine rheumatoid factors: molecular localization using a panel of mouse myeloma variant immunoglobulins.. The Journal of Experimental Medicine. 158(5). 1763–1768. 11 indexed citations

King, R, D. C. Burke, F.D. Northrop, & David S. Secher. (1983). Characterization and Properties of a Modified Human Interferon- -Containing an Additional 18 Amino Acids at the N-Terminus. Journal of General Virology. 64(8). 1815–1818. 3 indexed citations

10.

Berg, Kurt, David S. Secher, & Iver Heron. (1983). Purification and characterization of the HuIFN-alpha species.. PubMed. 41. 225–33. 1 indexed citations

11.

Scott, G.M., John H. Wallace, D. A. J. Tyrrell, et al.. (1982). Interim Report on Studies on "Toxic" Effects of Human Leucocyte-derived Interferon-Alpha (HuIFN-α). Journal of Interferon Research. 2(1). 127–130. 9 indexed citations

12.

Takei, Fumio, David S. Secher, C Milstein, & Timothy A. Springer. (1981). Use of a monoclonal antibody specifically non-reactive with T cells to delineate lymphocyte subpopulations.. PubMed. 42(3). 371–8. 29 indexed citations

13.

Secher, David S.. (1981). Immunoradiometric assay of human leukocyte interferon using monoclonal antibody. Nature. 290(5806). 501–503. 61 indexed citations

14.

Secher, David S.. (1978). Molecular immunology. Nature. 274(5673). 829–829. 1 indexed citations

15.

Secher, David S.. (1977). Multispecific antibodies. Nature. 268(5622). 689–690. 2 indexed citations

16.

Milstein, César, et al.. (1977). Molecular analysis of spontaneous somatic mutants. Nature. 265(5592). 299–304. 101 indexed citations

17.

Secher, David S., et al.. (1977). Somatic Mutants and Antibody Diversity. Immunological Reviews. 36(1). 51–72. 41 indexed citations

18.

Bridgen, John & David S. Secher. (1973). Molecular heterogeneity of alkaline phosphatase. FEBS Letters. 29(1). 55–57. 16 indexed citations

19.

Secher, David S., et al.. (1973). Spontaneous mutation in tissue culture — chemical nature of variant immunoglobulin from mutant clones of MOPC 21. FEBS Letters. 37(2). 311–316. 30 indexed citations

20.

Cotton, Richard G.H., David S. Secher, & César Milstein. (1973). Somatic mutation and the origin of antibody diversity. Clonal variability of the immunoglobulin produced by MOPC 21 cells in culture. European Journal of Immunology. 3(3). 135–140. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact